Measuring the psychosocial burden in women with low-grade abnormal cervical cytology in the TOMBOLA trial: psychometric properties of the Process and Outcome Specific Measure (POSM)

Hdl Handle:
http://hdl.handle.net/10147/344553
Title:
Measuring the psychosocial burden in women with low-grade abnormal cervical cytology in the TOMBOLA trial: psychometric properties of the Process and Outcome Specific Measure (POSM)
Authors:
Rothnie, Kieran; Cotton, Seonaidh C; Fielding, Shona; Gray, Nicola M; Little, Julian; Cruickshank, Margaret E; Walker, Leslie G; Avis, Mark; Sharp, Linda; in association with the TOMBOLA group
Citation:
Health and Quality of Life Outcomes. 2014 Nov 12;12(1):154
Issue Date:
12-Nov-2014
URI:
http://dx.doi.org/10.1186/s12955-014-0154-8; http://hdl.handle.net/10147/344553
Abstract:
Abstract Background There is a need for an instrument to measure the psychosocial burden of receiving an abnormal cervical cytology result which can be used regardless of the clinical management women receive. Methods 3331 women completed the POSM as part of baseline psychosocial assessment in a trial of management of low grade cervical cytological abnormalities. Factor analysis and reliability assessment of the POSM were conducted. Results Two factors were extracted from the POSM: Factor 1, containing items related to worry; and Factor 2 containing items relating to satisfaction with information and support received and change in the way women felt about themselves. Factor 1 had good reliability (Cronbach’s alpha 0.769), however reliability of the Factor 2 was poorer (0.482). Data collected at four subsequent time points demonstrated that the factor structure was stable over time. Conclusion This study demonstrates the presence and reliability of a scale measuring worries within the POSM. This analysis will inform its future use in this population and in other related contexts.
Language:
en
Keywords:
WOMEN'S HEALTH
Local subject classification:
CERVICAL CYTOLOGY

Full metadata record

DC FieldValue Language
dc.contributor.authorRothnie, Kieranen
dc.contributor.authorCotton, Seonaidh Cen
dc.contributor.authorFielding, Shonaen
dc.contributor.authorGray, Nicola Men
dc.contributor.authorLittle, Julianen
dc.contributor.authorCruickshank, Margaret Een
dc.contributor.authorWalker, Leslie Gen
dc.contributor.authorAvis, Marken
dc.contributor.authorSharp, Lindaen
dc.contributor.authorin association with the TOMBOLA groupen
dc.date.accessioned2015-02-17T12:47:44Zen
dc.date.available2015-02-17T12:47:44Zen
dc.date.issued2014-11-12en
dc.identifier.citationHealth and Quality of Life Outcomes. 2014 Nov 12;12(1):154en
dc.identifier.urihttp://dx.doi.org/10.1186/s12955-014-0154-8en
dc.identifier.urihttp://hdl.handle.net/10147/344553en
dc.description.abstractAbstract Background There is a need for an instrument to measure the psychosocial burden of receiving an abnormal cervical cytology result which can be used regardless of the clinical management women receive. Methods 3331 women completed the POSM as part of baseline psychosocial assessment in a trial of management of low grade cervical cytological abnormalities. Factor analysis and reliability assessment of the POSM were conducted. Results Two factors were extracted from the POSM: Factor 1, containing items related to worry; and Factor 2 containing items relating to satisfaction with information and support received and change in the way women felt about themselves. Factor 1 had good reliability (Cronbach’s alpha 0.769), however reliability of the Factor 2 was poorer (0.482). Data collected at four subsequent time points demonstrated that the factor structure was stable over time. Conclusion This study demonstrates the presence and reliability of a scale measuring worries within the POSM. This analysis will inform its future use in this population and in other related contexts.-
dc.language.isoenen
dc.subjectWOMEN'S HEALTHen
dc.subject.otherCERVICAL CYTOLOGYen
dc.titleMeasuring the psychosocial burden in women with low-grade abnormal cervical cytology in the TOMBOLA trial: psychometric properties of the Process and Outcome Specific Measure (POSM)en
dc.language.rfc3066en-
dc.rights.holderKieran Rothnie et al.; licensee BioMed Central Ltd.-
dc.description.statusPeer Reviewed-
dc.date.updated2014-12-01T20:04:38Z-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.